Vinyl Chemicals (VINYLINDIA)

Score breakdown: P/E: 1/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 1/1

Key Financials

Strengths

• Zero debt (D/E 0.00) gives the balance sheet a strong safety cushion.
• Promoter holding of 50.41% aligns management interest with minority shareholders.
• ROE of 16.71% and ROCE of 21.12% are respectable for a trading business.
• Dividend yield of 3.34% provides some income while waiting for better value.
• Sales growth of 15.77% shows the business is expanding its top line.

Concerns

• Profit declined 9.78% despite 15.77% sales growth, indicating a clear margin squeeze.
• P/E of 20.13 and P/B of 4.37 are expensive relative to book value of ₹61.94 and falling earnings.
• Piotroski F-score of 4/9 points to weak fundamental health.
• As a chemical trader, the business lacks pricing power and a durable economic moat; latest quarter net margin is only about 2.96% (₹5 Cr profit on ₹169 Cr sales).

AI Analysis

Vinyl Chemicals is a zero-debt chemical trader with a 50.41% promoter stake and a 3.34% dividend yield. At ₹270.87, the market capitalisation is ₹385 crore, translating to a P/E of 20.13 and a P/B of 4.37. The book value is ₹61.94, so I am paying a steep premium for a business whose return on equity is respectable at 16.71% and ROCE is 21.12%. But the latest quarter tells a cautionary tale: sales of ₹169 crore produced only ₹5 crore of net profit, and annual profit has fallen 9.78% despite 15.77% sales growth. That is a margin squeeze, common in a trading business without pricing power. In Graham's language, this is not an investment with a margin of safety; it is a speculation on chemical price cycles. The Piotroski F-score of 4/9 reinforces my discomfort—fundamental health is mediocre. There is no debt, and the dividend is a small comfort, but a 20 times earnings multiple with shrinking earnings is generous for a distributor. The PEG ratio of 1.28 seems misleading because it appears to be calculated on earnings growth that has turned negative. I would need a much lower price, or evidence that profit margins have stabilised and expanded, to call this a compelling buy. As Buffett, I prefer predictable businesses with durable moats. Chemical trading lacks that certainty—customers and suppliers can bypass intermediaries, and margins can evaporate. The 52-week range of ₹161 to ₹325 shows volatility, and the current price is in the upper half. For an Indian retail investor, patience matters. Wait for either a better price near the lower end of the range or a clear trend of rising profits. For now, this is a watchlist candidate, not a bargain.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer